Hormonal contraception
48 results
1 - 48
Modern hormonal contraception associated with increased risk of breast cancer- Certain hormonal contraceptives increase thromboembolism risk when taken with NSAIDs
- Women who use levonorgestrel-releasing intrauterine devices are less likely to develop ischemic stroke than nonusers of hormonal contraception
- High continuation of contraceptive ring vs patch
- Female hormone therapy is not associated with an increased risk of retinal artery or vein occlusion
- Oral contraceptives increase risk of thrombotic stroke and MI
- Low incidence of pregnancy with same-day-start contraception
- Fertility returns within 6 months for more than 50% of the women who stop using contraceptives
- Levonorgestrel is ineffective emergency contraception for obese women
- Long-acting contraceptive methods effective longer than approved duration
- Bariatric surgery associated with resolution of endometrial hyperplasia
- Contraceptive implant and LNG-IUD both reduce pelvic pain associated with endometriosis
- OC use associated with reduction in ovarian cancer risk
- DMPA associated with reduced risk for ovarian cancer
- Elagolix with add-back therapy effective for premenopausal heavy menstrual bleeding associated with fibroids
- Postpartum IUD placement at 2-4 wk = 6-8 wk, with caveats
- Prophylactic salpingo-oophorectomy reduces ovarian cancer risk
- Network analysis finds oral isotretinoin most effective for acne vulgaris
- Duration of vasomotor symptoms can be quite long during menopause
- Gabapentin ineffective for vulvodynia
- Migraine with aura associated with increased risk of CVD in women
- Saffron promising for treatment of PMS
- Levonorgestrel-releasing IUS effective for menorrhagia
- AHA/ACC guideline for the primary prevention of stroke
- Elagolix reduces pain but increases hot flushes/LDL and decreases BMD in women with mod-severe endometriosis